Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

被引:33
作者
Chen, Yuan-Gui [1 ]
Chen, Ming-Qiu [1 ]
Guo, Yu-Yan [1 ]
Li, Si-Cong [2 ]
Wu, Jun-Xin [3 ]
Xu, Ben-Hua [1 ]
机构
[1] Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China
[2] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA
[3] Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China
关键词
WEIGHTED MAGNETIC-RESONANCE; CHEMORADIATION THERAPY; RADIATION-THERAPY; RADIOCHEMOTHERAPY; CHEMOTHERAPY; MRI;
D O I
10.1371/journal.pone.0153944
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective To evaluate the predictive value of the apparent diffusion coefficient (ADC) for pathologic complete response (pCR) to neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer. Methods A total of 265 patients with rectal adenocarcinoma, whole Diffusion-Weighted MRI (DWI-MRI) images, clinically stage II to III (cT3-4 and/or cN+) and treated with NCRT followed by TME were screened. Fifty patients with pCR and another 50 patients without pCR with similar clinical charcacters and treatment regimens were selected for statistical analysis. All the patients' pre-CRT and post-CRT average ADC values were calculated from the coefficient maps created by DWI-MRI and recorded independently. The difference in the ADC values between the pCR and non-pCR was analyzed by the Mann-Whitney U test. The cut-off ADC value of the receiver operating characteristic (ROC) curve with pCR was then established. Results The mean pre- and post-ADC values in all patients, and in pCR patients and non-pCR patients were 0.879 +/- 0.06 and 1.383 +/- 0.11, 0.859 +/- 0.04 and 1.440 +/- 0.10, 0.899 +/- 0.07 and 1.325 +/- 0.09 (x10(-3)mm(2)/s), respectively. The difference between the pre-and post-ADC values in all patients, pCR patients, and non-pCR patients were considered to be statistically significant. The pre-ADC value was significantly lower in the pCR patients than in the non-pCR patients (p = 0.003), whereas the post-ADC values were significantly higher in the pCR patients than in the non-pCR patients. The percentage increase of the ADC value (Delta ADC%) in the pCR and non-pCR patients were 68% and 48% respectively (p<0.001). The ROC curves of the cut-off value of the pre-CRT patient ADC value was 0.866x10(-3)mm(2)/s. The AUC, sensitivity, specificity, PPV, NPV, and accuracy of diagnosing pCR were 0.670 (95% CI 0.563-0.777), 0.600, 0.640, 60%, 60%, and 60%, respectively. The cut-off value of Delta ADC% was 58%. The corresponding AUC, sensitivity, specificity, PPV, NPV, and accuracy of diagnosing pCR were 0.856 (95% CI 0.783-0.930), 0.800, 0.760, 76.9%, 79.2%, and 78%, respectively. Conclusions DWI-MRI technology can be efficient for predicting pCR for LARC after NCRT. Although the mean pre-CRT ADC value and the Delta ADC% are moderate predictors for pCR, the latter would be more accurate.
引用
收藏
页数:12
相关论文
共 28 条
[1]   Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations [J].
不详 .
NEOPLASIA, 2009, 11 (02) :102-125
[2]   Annual report on status of cancer in China, 2011 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Zeng, Hongmei ;
Zhang, Siwei ;
He, Jie .
CHINESE JOURNAL OF CANCER RESEARCH, 2015, 27 (01) :2-12
[3]   Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response [J].
Cho, Seung Hyun ;
Kim, Gab Chul ;
Jang, Yun-Jin ;
Ryeom, Hunkyu ;
Kim, Hye Jung ;
Shin, Kyung-Min ;
Park, Jun Seok ;
Choi, Gyu-Seog ;
Kim, See Hyung .
ACTA RADIOLOGICA, 2015, 56 (09) :1042-1050
[4]   Rectal Cancer: Assessment of Complete Response to Preoperative Combined Radiation Therapy with Chemotherapy-Conventional MR Volumetry versus Diffusion-weighted MR Imaging [J].
Curvo-Semedo, Lus ;
Lambregts, Doenja M. J. ;
Maas, Monique ;
Thywissen, Thomas ;
Mehsen, Rana T. ;
Lammering, Guido ;
Beets, Geerard L. ;
Caseiro-Alves, Filipe ;
Beets-Tan, Regina G. H. .
RADIOLOGY, 2011, 260 (03) :734-743
[5]   Diffusion MRI for prediction of response of rectal cancer to chemoradiation [J].
Dzik-Jurasz, A ;
Domenig, C ;
George, M ;
Wolber, J ;
Padhani, A ;
Brown, G ;
Doran, S .
LANCET, 2002, 360 (9329) :307-308
[6]   Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer [J].
Elmi, A. ;
Hedgire, S. S. ;
Covarrubias, D. ;
Abtahi, S. M. ;
Hahn, P. F. ;
Harisinghani, M. .
CLINICAL RADIOLOGY, 2013, 68 (10) :E524-E531
[7]   Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Preliminary results of a monoinstitutional prospective study [J].
Genovesi, D. ;
Filippone, A. ;
Cefaro, G. Ausili ;
Trignani, M. ;
Vinciguerra, A. ;
Augurio, A. ;
Di Tommaso, M. ;
Borzillo, V. ;
Sabatino, F. ;
Innocenti, P. ;
Liberatore, E. ;
Colecchia, G. ;
Tartaro, A. ;
Cotroneo, A. R. .
EJSO, 2013, 39 (10) :1071-1078
[8]   Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:: Results of FFCD 9203 [J].
Gerard, Jean-Pierre ;
Conroy, Thierry ;
Bonnetain, Franck ;
Bouche, Olivier ;
Chapet, Olivier ;
Closon-Dejardin, Marie-Therese ;
Untereiner, Michel ;
Leduc, Bernard ;
Francois, Eric ;
Maurel, Jean ;
Seitz, Jean-Francois ;
Buecher, Bruno ;
Mackiewicz, Remy ;
Ducreux, Michel ;
Bedenne, Laurent .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) :4620-4625
[9]   Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Glimelius, B. ;
Tiret, E. ;
Cervantes, A. ;
Arnold, D. .
ANNALS OF ONCOLOGY, 2013, 24 :81-88
[10]  
Greene FL, 2009, AJCC CANC STAGING MA